Comparison of IGLV2‐14 light chain sequences of patients with AL amyloidosis or multiple myeloma - Berghaus - 2023 - The FEBS Journal - Wiley Online Library
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
Multiple Myeloma: Navigating the First 90 Days - Conquer: the journey informed
UHL GP NEWS
Multiple Myeloma: Diagnosis and Treatment | AAFP
The Answer, My Friend, is Flowing in the Blood: How to Monitor Treatment Response in Myeloma
Serum Free Light Chain Assay in Diagnosis and Monitoring of Multiple Myeloma - Warde Medical Laboratory